Silarus Therapeutics' Series A Round

Silarus Therapeutics raised a round of funding on September 22, 2014.

Silarus Therapeutics is developing therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. Erythroferrone is a recently-discovered hormone that regulate…

Articles about Silarus Therapeutics' Series A Round: